baber/WOPTO huggingface dataset:
Patent ES-495801-A0 (ES)
IPC: B23B31/26
Filed: 1980-10-10
Abstract: A spindle extension, especially for drilling and milling machines, is required when machining large size workpieces. In order to enable the automatic tool change also when there is mounted the spindle extension with the available tools, the inventive spindle extension is provided with a chucking clamp which possesses a chucking or clamping pin which can be engaged by the chucking clamp of the tool spindle.
Patent ES-502970-A0 (ES)
IPC: C12N15/00
Filed: 1981-06-11
Abstract: Unglycosylated human fibroblast and leucocyte interferons are disclosed together with fused genes coding therefor.
Patent ES-507957-A0 (ES)
IPC: G21C7/32
Filed: 1981-12-14
Abstract: A spectral shift pressurized water reactor comprising apparatus (38) for inserting and withdrawing water displacer elements (40, 82) having differing neutron absorbing capabilities for selectively changing the watermoderator volume in the core (34) thereby changing the reactivity of the core. The displacer elements (40, 82) comprise substantially hollow cylindrical low neutron absorbing rods (40) and substantially hollow cylindrical- thick walled stainless rods (82). Since the stainless steel displacer rods have greater neutron absorbing capability, they can effect greater reactivity change per rod. However, by arranging fewer stainless steel displacer rods (82) in a cluster, the reactivity worth of the stainless steel displacer rod cluster can be less than a low neutron absorbing displacer rod cluster.
Patent ES-508124-A0 (ES)
IPC: A61K31/00
Filed: 1981-12-18
Abstract: Carbacyclin derivatives of Formula I    <IMAGE>  (I)  wherein R1 is OR2, wherein R2 is hydrogen, alkyl, cycloalkyl, aryl, a heterocyclic residue, or NHR3, wherein R3 is an acid residue or hydrogen; X is oxygen; A is -CH2-CH2-, trans-CH=CH-, or -C 3BOND C-; W is free or functionally modified hydroxymethylene or free or functionally modified   <IMAGE>  wherein the OH-group can be in the  alpha - or beta -position; D is a straight-chain or branched, saturated or unsaturated aliphatic group of 1-10 carbon atoms, which can optionally be substituted by fluorine atoms, 1,2-methylene, 1,1-trimethylene; E is -C 3BOND C- or -CR6=CH7- wherein R6 and R7 are hydrogen or alkyl of 1-5 carbon atoms; R4 is an aliphatic group, cycloalkyl, optionally substituted aryl, or a heterocyclic group; R5 is free or functionally modified hydroxy and, when R2 is hydrogen, the physiologically compatible salts thereof with bases, have valuable pharmacological properties.
Patent ES-510769-A0 (ES)
IPC: C21C7/064
Filed: 1982-03-24
Abstract: The disclosure relates to a process for the manufacture of desulfurizing agents containing 1-6 weight % chemically combined water, based on calcium oxide and carbon-containing calcium carbide, for crude iron and steel melts. More particularly, the disclosure provides for a molten mixture of calcium carbide and calcium oxide containing 20 to 80 weight % CaO to be made from lime and coke; for the mixture to be allowed to cool and solidify into a block; for the solidified block while it still has an average temperature of more than 400 DEG  C. to be crushed to particles with a size of less than 150 mm; for the comminuted mixture, which still has a temperature of at least 400 DEG  C. to be admixed with a quantity of calcium oxide necessary to establish in the resulting mixture a total content of CaO corresponding to the CaO content desired in the end product; and for the mixture to be gound while intensively mixing it with free carbon and carbonate in the presence of air or nitrogen with a moisture content of 5 to 20 g/m3 (at 1.013 bar and 273.15 K.) at temperatures below 100 DEG  C. to particles with a size of less than 10 mm.
Patent ES-514761-A0 (ES)
IPC: C08F4/62
Filed: 1982-08-05
Abstract: A process of preparing a catalyst component for the polymerization of  alpha -olefins. An organomagnesium compound is deposited on an inert inorganic support, such as silica, and the product obtained is heated at a temperature of 300-1000 DEG C in a non-reducing atmosphere. The support is then combined with one or more compounds of titanium and/or vanadium. The process of polymerizing alpha-olefins with these catalysts and a co-catalyst is also disclosed.
Patent ES-522223-A0 (ES)
IPC: C07D233/88
Filed: 1983-05-09
Abstract: Heretofore unavailable 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles; a novel process therefor, also advantageous for the preparation of known antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles; intermediate compounds therefor; and a method for treatment of ulcers in mammals therewith.
Patent ES-529746-A0 (ES)
IPC: C07D493/04
Filed: 1984-02-15
Abstract: The invention relates to pesticidal compositions comprising as active ingredient a compound of the general Formula I    <IMAGE>  (I) wherein R1 and R2 stand for hydrogen, optionally halogenosubstituted C1-6 alkyl or aryl; R3 and R4 are hydrogen, halogen or C1-6 alkyl; R5, R6, R7 and R8 are hydrogen, hydroxy, mercapto, amino, C1-10 alkyl; a group containing a methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, sec. butoxy, isobutoxy, tert. butoxy, n-pentyloxy, cyclopropyloxy, cyclobutyloxy, cyclopentyloxy, cyclohexyloxy, cycloheptyloxy, cyclooctyloxy, allyloxy, crotyloxy, prenyloxy, propargyloxy, substituted propargyloxy, C1-3 alkylenedioxy, aralkoxy, substituted aralkoxy, hydroxyalkoxy, alkoxyalkoxy, mercaptoalkoxyalkoxy, halogenoalkoxy, dihalogenoalkoxy, trihalogenoalkoxy, polyhalogenoalkoxy, N,N-dialkylaminoalkoxy, cycloalkylaminoalkoxy, alkylenoxy-alkyleneoxy, alkylene-thia-alkylenoxy or alkylene-aza-alkylenoxy unit or C2-6 acyl or a salt thereof and to a process for the preparation of the active ingredient.
Patent ES-537909-A0 (ES)
IPC: C07K17/14
Filed: 1984-11-23
Abstract: The present invention provides a process for the preparation of digitalis antibodies in which appropriate mammals are immunized with a digoxin bound to protein, the animal serum is obtained, the immune globulin-containing protein fraction is separated in known manner, the immunologically-active globulins are adsorbed on an immunologically-active column and separated from the other proteins, the antibodies are again eluted from the column and the Fab fractions are split with papain and purified, wherein, as immunologically-active adsorbent, there is used an inorganic matrix of large surface area to which digitoxin aldehyde is bound via a spacer which cannot be split with papain and the splitting off of the Fab fraction from the antibodies is carried out on the matrix. The present invention also provides digitalis antibodies obtained by this process, which antibodies can be used for the therapy of digitalis intoxications and for preparing immunological reagents for the determination of digitalis glycosides.
Patent ES-542098-A0 (ES)
IPC: E02D29/02
Filed: 1985-04-10
Abstract: In the technical field of supporting grid walls with a bulk material filling there is a substantial need of building elements of improved bearing capacity in relation to the construction mass as well as of good securing capacity for the bulk material filling.The solution according to the invention indicates a building element construction comprising longitudinal beams with profile legs (PS1, PS2), the first of which forms a bearing surface (F1) and the second a retaining surface (F2) for the bulk material filling. The first profile leg (PS1) has a wedge-shaped, particularly trapezoidal, cross-section. The cross-sectional height (H1) thereof increases from the outside inwards.
Patent ES-546039-A0 (ES)
IPC: C07K1/113
Filed: 1985-08-09
Abstract: This invention relates to a process for converting a teicoplanin-like compound into antibiotic L 17046 characterized in that a teicoplanin-like compound selected from teicoplanin complex, any further purified preparation thereof, teicoplanin factor A<sub>2'</sub> teicoplanin factor A<sub>3'</sub> each of the main components of teicoplanin factor A<sub>2</sub>, antibiotic L 17054 and a mixture of two or more of the above substances in any proportion is submitted to hydrolysis with a strong acid in the presence of a polar aprotic organic solvent selected from ethers, ketones and mixtures thereof that a room temperature are liquid.
Patent ES-549878-A0 (ES)
IPC: H04K1/00
Filed: 1985-12-12
Abstract: In the case of radio networks in tactical operation, special measures for jamming resistance to specific jammers are generally used only when jamming is to be expected or is already taking place, in view of the availability of the existing radio channels and the reduced transmission quality of the information to be transmitted which generally results. However, in the uncoded transmission of speech in analog form carried out in the normal way there is still the risk of a potential enemy infiltrating radiotelephone communication and causing confusion by imitating commands or messages. To prevent this, it is proposed to inject at the transmitting end short sound pulses (TI) into the voice signal (ASS) at pseudo-randomly varying time intervals (F), the sound pulses being evaluated at the receiving end to monitor for the infiltration of a potential enemy in the voice communication. <IMAGE>
Patent ES-551962-A0 (ES)
IPC: C07D311/04
Filed: 1986-02-13
Abstract: Chiral sorbinil intermediates of the formulawherein R is hydrogen or benzyloxycarbonyl and Y is hydroxy or amino, processes therefor, and processes forthe conversion thereof to sorbinil.
Patent FI-832486-A0 (FI)
Inventor: SCHAUB MICHAEL MISCHA
IPC: B65D6/02
Filed: 1983-07-06
Abstract: The novel case contains at least one rigid, obstacle-free basic frame element with a U-shaped profile and laterally fittable, interchangeable lateral elements. The latter can be in the form of e.g. plates, case shells or lateral covers provided with roller shutters. The case can be opened between the basic frame element and one of the lateral elements. The volume within the profile makes it possible to receive different additional elements. Examples of the latter are locking elements, carrying handles, name plates, identification elements, accessories, roller elements and carrying straps. The basic frame element can be in the form of a rectangle, square, polygon or circle.
Patent FI-871700-A0 (FI)
Inventor: SOUZA LAWRENCE M
IPC: C07K14/52
Filed: 1987-04-16
Abstract: Disclosed are novel polypeptides possessing part or all of the primary structural conformation and one or more of the biological properties of a mammalian (e.g., human) pluripotent granulocyte colony-stimulating factor ("hpG-CSF") which are characterized in preferred forms by being the product of procaryotic or eucaryotic host expression of an exogenous DNA sequence. Sequences coding for part or all of the sequence of amino acid residues of hpG-CSF or for analogs thereof may be incorporated into autonomously replicating plasmid or viral vectors employed to transform or transfect suitable procaryotic or eucaryotic host cells such as bacteria, yeast or vertebrate cells in culture. Products of expression of the DNA sequences display, e.g., the physical and immunological properties and in vitro biological activities of isolates of hpG-CSF derived from natural sources. Disclosed also are chemically synthesized polypeptides sharing the biochemical and immunological properties of hpG-CSF.
Patent FI-873536-A0 (FI)
Inventor: SELIN BJOERN
IPC: G06K15/00
Filed: 1987-08-14
Abstract: PCT No. PCT/SE86/00066 Sec. 371 Date Oct. 22, 1986 Sec. 102(e) Date Oct. 22, 1986 PCT Filed Feb. 17, 1986 PCT Pub. No. WO86/05004 PCT Pub. Date Aug. 28, 1986.An automatic printing machine for printing text on film has a main shaft (40) which is provided with an eccentric operative in driving a pressure-plate supporting slide via a knee joint which can be straightened/out by a rotary magnet (41). Arranged on the opposite side of the film path is an open bracket structure (30), on which a counter-pressure plate (30) is mounted. The pressure exerted by the counter-pressure plate can be varied with the aid of a force source which is independent of the bracket structure (30), and consequently the bracket structure does not need to take-up the counter-pressure exerted by the counter-pressure plate and is not subjected to said pressure.
Patent FI-873696-A0 (FI)
Inventor: HERBOTS IVAN
IPC: C11D3/20
Filed: 1987-08-26
Abstract: Detergent builder compositions comprise a mixture of tartrate succinate components and hydrocarbyl succinate components. The builder compositions provide detergent compositions which are especially useful for laundering fabrics.
Patent FI-891463-A0 (FI)
Inventor: GRUBER HARRY EDWARD
IPC: C07H19/052
Filed: 1989-03-28
Abstract: The use of an adenosine monophosphate deaminase inhibitor for the manufacture of a medicament to selectively enhance the extracellular concentration of adenosine in tissue having an undesired region of decreased blood flow is described.
Patent FI-893505-A0 (FI)
Inventor: REITER LAWRENCE ALAN
IPC: C07C335/06
Filed: 1989-07-20
Abstract: A process for preparing a compound of the formula <CHEM> wherein R is alkyl having one to six carbon atoms or benzyl, which comprises heating an S-alkyldithiobiuretium of the formula <CHEM> wherein R1 is alkyl having one to three carbon atoms with at least one molar equivalent of an amine of the formula  R-NH2 in a reaction-inert solvent. d
Patent FI-915759-A0 (FI)
Inventor: ARKENS CHARLES THOMAS
IPC: H01M50/423
Filed: 1991-12-05
Abstract: A multi-stage latex binder is disclosed. The latex binder comprises one stage which enhances the stiffness of the textile fibers and another stage which controls the coagulation temperature of the latex binder. The latex binder is particularly suitable for use in battery separators.
Patent FI-922592-A0 (FI)
Inventor: KOSLEY JR RAYMOND W
IPC: C07D211/30
Filed: 1992-06-04
Abstract: There are disclosed various compounds of the formula below <CHEM>  where  X is hydrogen, loweralkyl, loweralkoxy, hydroxy or nitro; Y is hydrogen or loweralkoxy; or alternatively, X ans Y combined together form the group -OCH2O- in which case the positions of X and Y on the benzene ring moiety must be adjacent to each other; Z is hydrogen, loweralkyl, loweralkoxy, hydroxy, halogen or nitro and n is 0 or 1, which compounds are useful for alleviating various memory dysfunction characterizied by a cholinergic deficit such as Alzheimer's disease.
Patent FI-940104-A0 (FI)
Inventor: REDDY REDREDDY SUKUMAR
IPC: E05B81/00
Filed: 1994-01-10
Abstract: Rotary locks used on transit vehicle doors when opened and closed by a rotating helical door drive member. In a preferred embodiment, a first lock utilizes a negative thread portion of the helical drive. A second lock utilizes a rotating lock pawl and stop. The drive and lock can be used to operate door systems with and without separate door hangers. Compensation for camber variations in car structure is provided through the use of spherical mounts or drive member journals.
Patent FI-942105-A0 (FI)
Inventor: THOMA RUDY
IPC: C07B59/00
Filed: 1994-05-06
Abstract: A method for introducing one or two radioactive iodine isotopes into the 3-position or 3,5-positions of the $g(a)-ring of an iodo thyronine compound, an iodo thyronamine compound or a thyro carboxylic acid, comprising the preparation of a corresponding thyronine derivative which has (a) substituent(s) in the 3-position or 3,5-positions of the $g(a)-ring exchangeable(s) for radio iodine and a melting point below 180 C, preferably below 145 C, the exchange of said substituents for one or two radioactive iodine isotopes being carried out essentially in the absence of solvents at temperatures in the vicinity of or above the melting point of said compound. Such a method is particularly advantageous when using as a starting compound a thyronine derivative containing one or two bromine atom(s) in the $g(a)-ring which is (are) exchangeable for an iodine nuclide.
Patent FI-943354-A0 (FI)
Inventor: STEFFENS GERD J
IPC: C12N15/58
Filed: 1994-07-14
Abstract: Bifunctional urokinase variants possessing improved fibrinolytic properties and thrombin inhibitory activities, plasmids used in the production of these polypeptides, as well as thrombolytic agents containing one of the bifunctional urokinase variants as active ingredient are described.
Patent FI-943738-A0 (FI)
Inventor: CANFIELD CRAIG
IPC: A61P31/04
Filed: 1994-08-12
Abstract: There are provided compounds of the formula   <IMAGE>   wherein R1 is a substituted or unsubstituted divalent aliphatic group of 1 to 16 carbon atoms; wherein the substituents are mono or poly and are selected from the group consisting of lower alkyl, aryl and arlkyl, R3 is selected from the group consisting of same group of values as R5, R5 is selected from the group consisting of substituted and unsubstituted alkyl of 1-10 carbon atoms, aryl, cycloalkyl and heterocycloalkyl of 3-8 carbon atoms, wherein the substituents are mono or poly and are selected from the group consisting of lower alkyl, cycloalkyl of 3-8 carbon atoms, lower alkenyl, lower alkynyl, nitro, lower alkoxy, lower alkoxycarbonyl, phenyl loweralkyl, phenyl, mono and polyhalophenyl, phenoxy, mono and polyhalophenoxy, R6 and R7 may be the same or different and are hydrogen, alkanoyl or alkoxyalkanoyl, R7 may also have the same value as R5, Y is oxygen or sulfur, m is 0 or 1, q is 0 or 1, wherein the prefix alk designates moieties which are straight chain or branched chain, and the term lower designates 1-6 carbon atoms and the unmodified term alk signifies 1-24 carbon atoms, the respective tautomers thereof, the pharmaceutically acceptable salts and addition salts thereof and the hydrates of said salts and addition salts. There are further provided methods of protecting subjects liable thereto from infections caused by an organism of the group Plasmodium sp., Mycobacterium sp. and Pneumocystis carinii by administering to a subject liable to such infection, a prophylactically effective amount of a compound of the foregoing formula. These compounds will also reduce the level of infection where said subjects have already been infected.
Patent FI-943870-A0 (FI)
Inventor: BREDERECK KARL
IPC: C08B3/06
Filed: 1994-08-23
Abstract: The process for the treatment of cellulose for activation for subsequent chemical reactions by bringing the cellulose in contact with liquid ammonia at a pressure higher than atmospheric pressure in a pressure vessel and subsequent expansion by rapid reduction of the pressure to atmospheric pressure, is carried out by using a cellulose pulp of an alpha-cellulose content of at least 92 mass %, letting the ammonia act on the pulp at room temperature or at a temperature higher than room temperature, after the expansion, removing the ammonia then still remaining in the pressure vessel except for a minimum content at which the state of activation reached by the action of the ammonia is still maintained and finally replacing the residual ammonia still needed to maintain the state of activation by another swelling or inclusion agent. The process is suitable, also on a large industrial scale, especially for the activation of pulp subsequently to be acetylated and makes possible to achieve a homogenous and high-grade activation. Further, no costly cooling apparatus is needed.
Patent FI-970777-A0 (FI)
Inventor: SOLID INFORMATION TECHNOLOGY
IPC: G06F17/30
Filed: 1997-02-24
Abstract: A plurality of steps, which are intended to modify the data in a transaction, form a transaction (40) comprising statements (41, 42, 43). In the method according to the invention there is formed a data exchange space (47) common to the transaction in order to make the parameters available to the statements belonging to the transaction and in order to transmit data between the statements belonging to the transaction. The system (30) maintaining the first version of the database is arranged to store the modifications to be made in the database as transactions, which comprise statements as well as parameters, both regarding the statements and regarding the transaction. The system (31) maintaining the second database version is arranged to form a transaction on the basis of the message it receives, whereby the transaction comprises statements, and to reserve an information exchange space (47) in the system memory in order to make the parameters available to the statements belonging to the transaction and in order to transmit data between the statements belonging to the transaction. <IMAGE>
Patent IL-65633-A0 (IL)
Title: Polyurethane foam
IPC: C08G18/00
Filed: 1982-04-27
Abstract: High resilience foams are produced by the reaction of a polyol containing primary hydroxy groups and an isocyanate containing a substantial proportion of toluene diisocyanate isomers using as sole effective catalyst, a quaternary ammonium carboxylate derivative of a tertiary amine, which tertiary amine contains no reactive hydroxy groups.
Patent IL-68769-A0 (IL)
Title: Pharmaceutical compositions containing insulin
IPC: A61K38/55
Filed: 1983-05-23
Abstract: The invention provides a pharmaceutical composition for the oral administration of insulin comprising insulin, a bile acid or alkali metal salt thereof, the bile acid being selected from the group consisting of cholic acid, chenodeoxycholic acid, taurocholic acid, taurochenodeoxycholic acid, glycocholic acid, glycochenocholic acid, 3β-hydroxy-12- ketocholic acid, 12α-3β-dihydrocholic acid, and ursodesoxycholic acid, and a protease inhibitor, the composition being provided with an enterocoating to assure passage through the stomach and release in the intestine.
Patent IL-72017-A0 (IL)
Title: Wire race bearing with rolling contact
IPC: F16C27/04
Filed: 1984-06-04
Abstract: The bearing with rolling contact consists of wire elements (2, 4) which serve as raceways for the rolling elements (1), and an inner bearing ring (3) and an outer bearing ring (5). An insert is fitted between at least one wire element (2) and its associated wire bed (6) in the bearing ring in question (3), and this insert is designed as a tubular pressure pad (7).
Patent IL-79965-A0 (IL)
Title: Pharmaceutical composition comprising an angiotensin converting enzyme inhibitor for the treatment of high blood pressure
IPC: A61P43/00
Filed: 1986-09-08
Abstract: The preparation contains an angiotensin converting enzyme inhibitor and a loop diuretic.
Patent IL-87778-A0 (IL)
Title: Pharmaceutical compositions containing stabilized therapeutically active proteins and their preparation
IPC: A61K9/10
Filed: 1988-09-16
Abstract: The pharmaceutical preparations are for topical use, contain one or more stabilised therapeutically active proteins and, where appropriate, customary auxiliaries, vehicles and additives, and are prepared as described using physiologically tolerated hydrophobic substances for stabilising proteins.
Patent FI-20002496-A0 (FI)
Inventor: METSAERINTA MAIJA-LEENA
IPC: C22B1/10
Filed: 2000-11-15
Abstract: The present invention relates to method, which helps to reduce and remove the build-up forming on the grate of a fluidized-bed furnace in the roasting of fine-grained material such as concentrate. The concentrate is fed into the roaster from the wall of the furnace, and oxygen-containing gas is fed via gas nozzles under the grate in the bottom of the furnace in order to fluidize the concentrate and oxidize it during fluidization. Below the concentrate feed point, or feed grate, the oxygen content of the gas to be fed is raised compared with the oxygen content of the gas fed elsewhere.